WEKO3
アイテム
Current Real-World Status of Oral Anticoagulant Management in Japanese Patients
https://tokushima-u.repo.nii.ac.jp/records/2012323
https://tokushima-u.repo.nii.ac.jp/records/2012323fc371713-354d-42bb-ae01-ce56fc724667
| 名前 / ファイル | ライセンス | アクション |
|---|---|---|
circj_89_2_150.pdf (336 KB)
|
.png)
|
| Item type | 文献 / Documents(1) | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 公開日 | 2024-11-26 | |||||||||||||||||
| アクセス権 | ||||||||||||||||||
| アクセス権 | open access | |||||||||||||||||
| 資源タイプ | ||||||||||||||||||
| 資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||||||||||||||
| 資源タイプ | journal article | |||||||||||||||||
| 出版社版DOI | ||||||||||||||||||
| 識別子タイプ | DOI | |||||||||||||||||
| 関連識別子 | https://doi.org/10.1253/circj.CJ-24-0827 | |||||||||||||||||
| 言語 | ja | |||||||||||||||||
| 関連名称 | 10.1253/circj.CJ-24-0827 | |||||||||||||||||
| 出版タイプ | ||||||||||||||||||
| 出版タイプ | VoR | |||||||||||||||||
| 出版タイプResource | http://purl.org/coar/version/c_970fb48d4fbd8a85 | |||||||||||||||||
| タイトル | ||||||||||||||||||
| タイトル | Current Real-World Status of Oral Anticoagulant Management in Japanese Patients | |||||||||||||||||
| 言語 | en | |||||||||||||||||
| タイトル別表記 | ||||||||||||||||||
| その他のタイトル | Oral Anticoagulant Management in Japan | |||||||||||||||||
| 言語 | en | |||||||||||||||||
| 著者 |
原, 知也
× 原, 知也
WEKO
1486
× 佐田, 政隆
WEKO
309
|
|||||||||||||||||
| 抄録 | ||||||||||||||||||
| 内容記述タイプ | Abstract | |||||||||||||||||
| 内容記述 | Anticoagulant therapy is a drug therapy that inhibits the formation of blood clots. Although anticoagulants are effective in preventing thromboembolism, they also carry the risk of bleeding, so they must be managed carefully, taking both efficacy and safety into account. Evidence regarding the effectiveness and safety of each anticoagulant has already accumulated through many large clinical trials and post-marketing surveillance. However, when making decisions in clinical practice, it is necessary to always take into consideration differences in patient populations between clinical trials and actual clinical practice, as well as differences in historical background. (For example, there are differences in antiplatelet drugs and coronary artery interventions that were mainly used in each era.) In this review we discuss the effectiveness and safety of currently used anticoagulants, focusing on different patient backgrounds and points to keep in mind regarding their proper use, based on the latest reports in Asian populations, especially Japanese people, over the past 1–2 years. | |||||||||||||||||
| 言語 | en | |||||||||||||||||
| キーワード | ||||||||||||||||||
| 言語 | en | |||||||||||||||||
| 主題Scheme | Other | |||||||||||||||||
| 主題 | Anticoagulant | |||||||||||||||||
| キーワード | ||||||||||||||||||
| 言語 | en | |||||||||||||||||
| 主題Scheme | Other | |||||||||||||||||
| 主題 | Atrial fibrillation | |||||||||||||||||
| キーワード | ||||||||||||||||||
| 言語 | en | |||||||||||||||||
| 主題Scheme | Other | |||||||||||||||||
| 主題 | Venous thromboembolism | |||||||||||||||||
| 書誌情報 |
en : Circulation Journal 巻 89, 号 2, p. 150-152, 発行日 2024-11-15 |
|||||||||||||||||
| 収録物ID | ||||||||||||||||||
| 収録物識別子タイプ | EISSN | |||||||||||||||||
| 収録物識別子 | 13474820 | |||||||||||||||||
| 収録物ID | ||||||||||||||||||
| 収録物識別子タイプ | PISSN | |||||||||||||||||
| 収録物識別子 | 13469843 | |||||||||||||||||
| 出版者 | ||||||||||||||||||
| 出版者 | The Japanese Circulation Society | |||||||||||||||||
| 言語 | en | |||||||||||||||||
| 権利情報 | ||||||||||||||||||
| 言語 | en | |||||||||||||||||
| 権利情報 | This article is licensed under a Creative Commons [Attribution-NonCommercial-NoDerivatives 4.0 International] license. https://creativecommons.org/licenses/by-nc-nd/4.0/ | |||||||||||||||||
| EID | ||||||||||||||||||
| 識別子 | 415164 | |||||||||||||||||
| 識別子タイプ | URI | |||||||||||||||||
| 言語 | ||||||||||||||||||
| 言語 | eng | |||||||||||||||||
